From BALCO to Bioethics, Harvard
Details of a meeting where I will give a presentation on gene doping:
Venue: Boston, USA: E.LaB Event Description
The Harvard Law School Ethics, Law & Biotechnology Society (E.LaB) in conjunction with the Harvard Committee on Sports and Entertainment Law (CSEL) & HL Central are proud to present “From BALCO to Bioethics: The Present and Future of Performance Enhancement in Sport.” The ongoing and highly publicized BALCO controversy has made the topic of performance enhancement among athletes one of substantial current interest and debate. While BALCO controls the headlines of today, and poses difficult questions for professional and amateur sports, we pause to speculate about what the future of performance enhancement in athletics may hold.
This panel discussion will feature Dr. Olivier Rabin, Director of Science for the World Anti-Doping Agency, Dr. Dan Brock, Director of the Division of Medical Ethics at Harvard Medical School, and Dr. Andy Miah, Lecturer in Media, Bioethics and Cyberculture at the University of Paisley, Scotland. The panel will be moderated by Dr. Gil Siegal, visiting professor and Medical Ethics Fellow at Harvard Medical School.
Please join us for an open dialogue about the present and future state of performance enhancement in sport.
Where: Harvard Law School, Langdell South Classroom
When: Monday April 11, 2005. 7-9pm.
Contact: Dan Vorhaus (dvorhaus@law.harvard.edu) for more information.
Venue: Boston, USA: E.LaB Event Description
The Harvard Law School Ethics, Law & Biotechnology Society (E.LaB) in conjunction with the Harvard Committee on Sports and Entertainment Law (CSEL) & HL Central are proud to present “From BALCO to Bioethics: The Present and Future of Performance Enhancement in Sport.” The ongoing and highly publicized BALCO controversy has made the topic of performance enhancement among athletes one of substantial current interest and debate. While BALCO controls the headlines of today, and poses difficult questions for professional and amateur sports, we pause to speculate about what the future of performance enhancement in athletics may hold.
This panel discussion will feature Dr. Olivier Rabin, Director of Science for the World Anti-Doping Agency, Dr. Dan Brock, Director of the Division of Medical Ethics at Harvard Medical School, and Dr. Andy Miah, Lecturer in Media, Bioethics and Cyberculture at the University of Paisley, Scotland. The panel will be moderated by Dr. Gil Siegal, visiting professor and Medical Ethics Fellow at Harvard Medical School.
Please join us for an open dialogue about the present and future state of performance enhancement in sport.
Where: Harvard Law School, Langdell South Classroom
When: Monday April 11, 2005. 7-9pm.
Contact: Dan Vorhaus (dvorhaus@law.harvard.edu) for more information.
0 Comments:
Post a Comment
<< Home